Bimeda News

Bimeda® US Launches SpectoGard® (spectinomycin sulfate) Sterile Solution

Oakbrook Terrace, Illinois (July 19, 2023) – Bimeda Inc. is pleased to announce that SpectoGard (spectinomycin sulfate) Sterile Solution—which received FDA approval in September of 2022—is now availab...

Jim Lovin, Strategic Accounts Manager-Swine

Bimeda is pleased to announce the appointment of Jim Lovin as a Strategic Accounts Manager - Swine. Jim will focus on the development and management of both core Bimeda products and custom vaccine lin...

Bimeda Biologicals® Launches Stimulator® 5 + PMH

Bimeda Biologicals® is pleased to announce the newest addition to their Stimulator® line of modified live virus (MLV) vaccines: Stimulator® 5 + PMH. With this launch, Bimeda Biologicals adds to their ...

Bimeda® Announces Sponsorship of Hagyard Equine Medical Institute’s new Podcast The Spirit of Hagyard

Bimeda® Inc. is thrilled to announce their new partnership with The Spirit of Hagyard podcast. Created in 2022, the podcast was developed by Hagyard Equine Medical Institute, a renowned equine veterin...

Bimeda Appoints CFO, Adam Reizer

Bimeda Inc is pleased to announce the appointment of Adam Reizer as the Chief Financial Officer for Bimeda North America. Adam reports to Gavin Tierney, CEO. Adam was born and raised in Chicago, IL. H...

Bimeda Acquires Afrivet

Global veterinary pharmaceutical and animal health specialist Bimeda has announced its latest significant investment, via the acquisition of South Africa's leading animal health distributor, Afrivet S...

Bimeda Launches Sustainability-Focused Website, onebimeda.com

Bimeda is pleased to announce the launch of a new sustainability-focused website, onebimeda.com. The website details Bimeda's sustainability mission statement and the five Sustainability Pillars which...

Bimeda Welcomes Samuel Cossio

Bimeda is pleased to announce the appointment of Samuel Cossio as Territory Sales Manager for the states of Idaho, Oregon, and Washington. Sam will be part of the livestock sales team and assist in th...

Bimeda® Announces First Generic Ketoprofen Injection for Horses, Ketomed™

Bimeda® Inc. announced today the release of KetoMed™ (ketoprofen) (ANADA 200 – 625) for the alleviation of inflammation and pain associated with musculoskeletal disorders in horses. This launch marks ...

Bimeda® Announces Re-introduction of Ovacyst® and Prostamate®

Oakbrook Terrace, Illinois- March 7, 2022- Bimeda® Animal Health has announced the expansion of its US product portfolio with the re-introduction of OvaCyst® (gonadorelin) and ProstaMate® (dinoprost t...